Blood Safety (Industry News)

Testing System Selected by Australian Red Cross Blood Service To Screen Blood Supply

Published in Blood Weekly, January 13th, 2000

Chiron Corporation announced that the Australian Red Cross Blood Service (ARCBS) will use the company's nucleic acid testing (NAT) system to screen the country's entire blood supply for hepatitis C (HCV) and the human immunodeficiency virus-1 (HIV).

Chiron's combination HIV/HCV test, developed and manufactured by Gen-Probe Incorporated, is expected to be fully implemented in Australia by mid-2000. The advanced screening test, which incorporates sophisticated new technology, will be used to routinely screen the Australian blood supply, approximately 1 million blood donations per year.

"The ARCBS's adoption of NAT technology is another step towards...

Want to see the full article?

Purchase this article for only $3.00

We're a pay-per-view site for premium content. If you'd like to purchase this article, it's only $3.00.

Welcome to NewsRx!

Learn more about a six-week, no-risk free trial of Blood Weekly

Source: Blood Weekly (2000-01-13)

NewsRx is Social

Top Medical Newsletters

Awards

Best Health/Healthcare Content, 2012
Best Health/Healthcare Content, 2011
Best e-Business Site, 2010
Best e-Business Site, 2009
Best e-Business Site, 2008
Best e-Business Site, 2007
Best e-Business Site, 2006
Best Healthcare Content, 2005
Best Overall Internet Site, 2005
Best Interactive Site, 2005

Facts & Stats

NewsRx also is available at LexisNexis, Gale, ProQuest, Factiva, Dialog, Thomson Reuters, NewsEdge, and Dow Jones.

Google 2010 PageRank: #2 Among Top Health News and Media Publications
Google 2010 PageRank: #2 Among Top Science Publications in Biology/Physiology
Google 2010 PageRank: #2 Among Top News and Media for the Business of Pharmaceuticals
Amazon's Alexa 2010 PageRank: #2 News and Media Site for the Pharmaceutical Industry